AZN AstraZeneca Plc: Rasio total nilai perusahaan marang pendapatan

Logo perusahaan publik AstraZeneca Plc (AZN)

AstraZeneca PLC (AZN) dominance in oncology and protection against generics ensure high margins, as confirmed by the EV/Sales history. The 4779.40 mark indicates the enterprise value-to-revenue valuation level. Its status as a global innovator guarantees physician trust, while colossal R&D expenditures and strict government regulation create insurmountable barriers to entry for new players.

AZN (AstraZeneca Corp.) riwayat Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Rincian metrik keuangan lan pasar AstraZeneca (AZN)

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental perusahaan:AZN, astrazeneca.com
Produk seri astrazeneca.com

This metric combines market capitalization and net debt, comparing the total cost of acquiring the business with its annual turnover. This metric allows for the determination of the market asset value multiple, adjusted for debt load, to identify undervaluation or stagnation. The efficiency of AstraZeneca PLC (AZN) plants in the US and Europe directly impacts revenue, making the EV/Sales business valuation a key indicator of operational resilience.